A detailed history of Delta Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Delta Investment Management, LLC holds 3,786 shares of ABBV stock, worth $681,480. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,786
Previous 3,788 0.05%
Holding current value
$681,480
Previous $649,000 15.1%
% of portfolio
0.17%
Previous 0.16%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $327 - $398
-2 Reduced 0.05%
3,786 $747,000
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $23,837 - $27,837
154 Added 4.24%
3,788 $649,000
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $63,768 - $72,657
-399 Reduced 9.89%
3,634 $661,000
Q4 2023

Feb 02, 2024

BUY
$137.6 - $154.97 $4,128 - $4,649
30 Added 0.75%
4,033 $624,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $133 - $154
1 Added 0.02%
4,003 $596,000
Q2 2023

Aug 03, 2023

BUY
$132.51 - $164.9 $265 - $329
2 Added 0.05%
4,002 $539,000
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $1,735 - $1,998
-12 Reduced 0.3%
4,000 $637,000
Q4 2022

Jan 19, 2023

BUY
$138.31 - $165.87 $1,936 - $2,322
14 Added 0.35%
4,012 $0
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $1,610 - $1,847
-12 Reduced 0.3%
3,998 $537,000
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $22,569 - $28,693
-164 Reduced 3.93%
4,010 $614,000
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $395 - $491
3 Added 0.07%
4,174 $677,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $322 - $407
3 Added 0.07%
4,171 $565,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $14,576 - $16,546
137 Added 3.4%
4,168 $450,000
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $161,838 - $178,164
-1,582 Reduced 28.18%
4,031 $436,000
Q4 2020

Feb 04, 2021

SELL
$80.49 - $108.67 $1,287 - $1,738
-16 Reduced 0.28%
5,613 $601,000
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $16,580 - $19,460
-193 Reduced 3.32%
5,629 $493,000
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $38,592 - $51,642
526 Added 9.93%
5,822 $571,000
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $124,291 - $188,441
1,927 Added 57.2%
5,296 $403,000
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $243,005 - $304,052
3,369 New
3,369 $298,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Delta Investment Management, LLC Portfolio

Follow Delta Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Investment Management, LLC with notifications on news.